Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 969168, 6 pages
http://dx.doi.org/10.1155/2014/969168
Research Article

American Ginseng Extract (Panax quinquefolius L.) Is Safe in Long-Term Use in Type 2 Diabetic Patients

1Centre for Applied Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10 000 Zagreb, Croatia
2Clinical Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital, Li Ka Shing Knowledge Institute, Toronto, ON, Canada M5C 2T2
3Departments of Nutritional Sciences and Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada M5S 3E2
4Department of Endocrinology, Diabetes and Metabolic Disease, Dubrava University Hospital, University of Zagreb, 10 000 Zagreb, Croatia
5Clinical Department of Laboratory Diagnostics, Dubrava University Hospital, University of Zagreb, 10 000 Zagreb, Croatia

Received 3 March 2014; Accepted 14 April 2014; Published 7 May 2014

Academic Editor: Chang-Gue Son

Copyright © 2014 Iva Mucalo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Diabetes Federation, IDF Diabetes Atlas, 6th edition, 2013.
  2. S. E. Inzucchi, R. M. Bergenstal, J. B. Buse et al., “Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD),” Diabetologia, vol. 35, no. 6, pp. 1364–1379, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Bell, C. K. Suerken, J. G. Grzywacz, W. Lang, S. A. Quandt, and T. A. Arcury, “Complementary and alternative medicine use among adults with diabetes in the United States,” Alternative Therapies in Health and Medicine, vol. 12, no. 5, pp. 16–22, 2006. View at Google Scholar · View at Scopus
  4. G. Y. Yeh, D. M. Eisenberg, R. B. Davis, and R. S. Phillips, “Use of complementary and alternative medicine among persons with diabetes mellitus: results of a national survey,” American Journal of Public Health, vol. 92, no. 10, pp. 1648–1652, 2002. View at Google Scholar · View at Scopus
  5. G. Y. Yeh, D. M. Eisenberg, T. J. Kaptchuk, and R. S. Phillips, “Systematic review of herbs and dietary supplements for glycemic control in diabetes,” Diabetes Care, vol. 26, no. 4, pp. 1277–1294, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. N.-H. Lee and C.-G. Son, “Systematic review of randomized controlled trials evaluating the efficacy and safety of ginseng,” JAMS Journal of Acupuncture and Meridian Studies, vol. 4, no. 2, pp. 85–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. P. M. Barnes, B. Bloom, and R. L. Nahin, “Complementary and alternative medicine use among adults and children: United States, 2007,” National Health Statistics Reports, no. 12, pp. 1–23, 2009. View at Google Scholar · View at Scopus
  8. J. T. Coon and E. Ernst, “Panax ginseng: a systematic review of adverse effects and drug interactions,” Drug Safety, vol. 25, no. 5, pp. 323–344, 2002. View at Google Scholar · View at Scopus
  9. P. M. Stavro, M. Woo, T. F. Heim, L. A. Leiter, and V. Vuksan, “North American ginseng exerts a neutral effect on blood pressure in individuals with hypertension,” Hypertension, vol. 46, no. 2, pp. 406–411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. P. M. Stavro, M. Woo, L. A. Leiter, T. F. Heim, J. L. Sievenpiper, and V. Vuksan, “Long-term intake of North American ginseng has no effect on 24-hour blood pressure and renal function,” Hypertension, vol. 47, no. 4, pp. 791–796, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. R. K. Siegel, “Ginseng abuse syndrome. Problems with the panacea,” Journal of the American Medical Association, vol. 241, no. 15, pp. 1614–1615, 1979. View at Publisher · View at Google Scholar · View at Scopus
  12. P. B. Fontanarosa and G. D. Lundberg, “Alternative medicine meets science,” Journal of the American Medical Association, vol. 280, no. 18, pp. 1618–1619, 1998. View at Google Scholar · View at Scopus
  13. I. Mucalo, E. Jovanovski, D. Rahelic, V. Bozikov, Z. Romic, and V. Vuksan, “Effect of American ginseng (Panax quinquefolius L.) on arterial stiffness in subjects with type-2 diabetes and concomitant hypertension,” Journal of Ethnopharmacology, vol. 150, no. 1, pp. 148–153, 2013. View at Publisher · View at Google Scholar
  14. V. Vuksan and J. L. Sievenpiper, “Herbal remedies in the management of diabetes: lessons learned from the study of ginseng,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 15, no. 3, pp. 149–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. E. Ware Jr. and C. D. Sherbourne, “The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection,” Medical Care, vol. 30, no. 6, pp. 473–483, 1992. View at Google Scholar · View at Scopus
  16. E. Ernst, “The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava,” Annals of Internal Medicine, vol. 136, no. 1, pp. 42–53, 2002. View at Google Scholar · View at Scopus
  17. L. G. Miller, “Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions,” Archives of Internal Medicine, vol. 158, no. 20, pp. 2200–2211, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. U. Sonnenborn and R. Hansel, “Panax ginseng,” in Adverse Reactions of Herbal Drugs, P. A. G. M. De Smet, K. Keller, R. Hänsel, and R. F. Chandler, Eds., pp. 179–192, Springer, Berlin, Germany, 1992. View at Google Scholar
  19. M. J. Cupp, Toxicology and Clinical Pharmacology of Herbal Products, Humana Press, Totowa, NJ, USA, 2000.
  20. B. K. Vogler, M. H. Pittler, and E. Ernst, “The efficacy of ginseng. A systematic review of randomised clinical trials,” European Journal of Clinical Pharmacology, vol. 55, no. 8, pp. 567–575, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. World Health Organization, WHO Monograph on Selected Medicinal Plants, vol. 4, 2009.
  22. S. Dharmananda, “The nature of ginseng. Traditional use, modern research, and the question of dosage,” HerbalGram, vol. 54, pp. 34–51, 2002. View at Google Scholar
  23. M. Blumenthal, Part Two Monographs: Approved Herbs. The Complete German Commission E Monographs: therapeutic Guide To Herbal Medicine, The American Botanical Council, Austin, Tex, USA, 1998.
  24. World Health Organization, WHO Monographs on Selected Medicinal Plants. Radix Ginseng, vol. 1, Geneva, Switzerland, 1999.
  25. J. L. Sievenpiper, J. T. Arnason, E. Vidgen, L. A. Leiter, and V. Vuksan, “A systematic quantitative analysis of the literature of the high variability in ginseng (Panax spp.): should ginseng be trusted in diabetes?” Diabetes Care, vol. 27, no. 3, pp. 839–840, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. J. L. Sievenpiper, J. T. Arnason, L. A. Leiter, and V. Vuksan, “Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: the role of ginsenosides,” Journal of the American College of Nutrition, vol. 23, no. 3, pp. 248–258, 2004. View at Google Scholar · View at Scopus